Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ICAD

iCAD

$3.06

-0.24 (-7.27%)

08:09
10/11/18
10/11
08:09
10/11/18
08:09
Hot Stocks
iCAD announces clinical results for DBT cancer detection software »

iCAD announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

ICAD

iCAD

$3.12

0.01 (0.32%)

08:09
10/09/18
10/09
08:09
10/09/18
08:09
Hot Stocks
iCAD's Xoft system selected by SUNY Upstate Medical University »

iCAD, Inc. announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

Over a month ago
ICAD

iCAD

$3.00

0.08 (2.74%)

08:10
08/29/18
08/29
08:10
08/29/18
08:10
Hot Stocks
iCAD receives AERB approval for Xoft System in India »

iCAD announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARCT

Arcturus Therapeutics

$8.08

0.12 (1.51%)

, ICAD

iCAD

$2.92

0.05 (1.74%)

07:07
08/28/18
08/28
07:07
08/28/18
07:07
Hot Stocks
Arcturus Therapeutics appoints Andrew Sassine interim CFO »

Arcturus Therapeutics…

ARCT

Arcturus Therapeutics

$8.08

0.12 (1.51%)

ICAD

iCAD

$2.92

0.05 (1.74%)

GEMP

Gemphire Therapeutics

$1.39

-0.05 (-3.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

ICAD

iCAD

$2.96

0.02 (0.68%)

08:04
08/08/18
08/08
08:04
08/08/18
08:04
Hot Stocks
iCAD receives FDA clearance of PowerLook Density Assessment »

iCAD announced FDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
ICAD

iCAD

$3.41

0.22 (6.90%)

08:03
04/19/18
04/19
08:03
04/19/18
08:03
Hot Stocks
iCAD presents 'positive' clinical data on Xoft Axxent Electronic eBx system »

iCAD announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICAD

iCAD

$3.43

-0.0402 (-1.16%)

06:30
03/01/18
03/01
06:30
03/01/18
06:30
Hot Stocks
iCAD granted CE Mark approval in Europe for AI cancer detection solution »

iCAD received CE Mark…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGL

AGL Resources

$0.00

(0.00%)

, ARCT

Arcturus Therapeutics

$9.28

-0.32 (-3.33%)

04:55
01/10/18
01/10
04:55
01/10/18
04:55
Conference/Events
LifeSci Advisors to hold a conference »

LifeSci Advisors…

AGL

AGL Resources

$0.00

(0.00%)

ARCT

Arcturus Therapeutics

$9.28

-0.32 (-3.33%)

CRMD

CorMedix

$0.55

-0.0053 (-0.95%)

GLMD

Galmed

$11.77

0.15 (1.29%)

COOL

Ticker changed to PTE

$24.98

1.27 (5.36%)

ICAD

iCAD

$3.64

-0.01 (-0.27%)

CYAD

Celyad

$45.20

-1.75 (-3.73%)

HTGM

HTG Molecular

$3.18

-0.22 (-6.47%)

NERV

Minerva

$5.35

-0.2 (-3.60%)

NTEC

Intec Pharma

$6.80

-0.2 (-2.86%)

CTSO

CytoSorbents

$7.40

-0.1 (-1.33%)

RXDX

Ignyta

$27.00

(0.00%)

TXMD

TherapeuticsMD

$6.39

-0.01 (-0.16%)

VBIV

VBI Vaccines

$4.38

-0.01 (-0.23%)

VRML

Vermillion

$1.86

-0.01 (-0.53%)

MRTX

Mirati Therapeutics

$19.05

1.85 (10.76%)

FBIO

Fortress Biotech

$4.08

-0.06 (-1.45%)

FOMX

Foamix

$6.05

-0.13 (-2.10%)

BDSI

BioDelivery Sciences

$2.90

0.05 (1.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

  • 10

    Jan

  • 26

    Feb

  • 29

    May

AGL

AGL Resources

$0.00

(0.00%)

, ARCT

Arcturus Therapeutics

$9.60

0.13 (1.37%)

04:55
01/09/18
01/09
04:55
01/09/18
04:55
Conference/Events
LifeSci Advisors to hold a conference »

LifeSci Advisors…

AGL

AGL Resources

$0.00

(0.00%)

ARCT

Arcturus Therapeutics

$9.60

0.13 (1.37%)

CRMD

CorMedix

$0.56

0.0031 (0.56%)

GLMD

Galmed

$11.62

0.92 (8.60%)

COOL

Ticker changed to PTE

$23.71

-0.35 (-1.45%)

ICAD

iCAD

$3.65

-0.23 (-5.93%)

CYAD

Celyad

$46.95

0.45 (0.97%)

HTGM

HTG Molecular

$3.40

-0.07 (-2.02%)

NERV

Minerva

$5.55

-0.45 (-7.50%)

NTEC

Intec Pharma

$7.00

-0.05 (-0.71%)

CTSO

CytoSorbents

$7.50

0.45 (6.38%)

RXDX

Ignyta

$27.00

(0.00%)

TXMD

TherapeuticsMD

$6.40

-0.02 (-0.31%)

VBIV

VBI Vaccines

$4.39

-0.05 (-1.13%)

VRML

Vermillion

$1.87

0.02 (1.08%)

MRTX

Mirati Therapeutics

$17.20

-1.5 (-8.02%)

FBIO

Fortress Biotech

$4.14

-0.06 (-1.43%)

FOMX

Foamix

$6.18

-0.1 (-1.59%)

BDSI

BioDelivery Sciences

$2.85

-0.15 (-5.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

  • 09

    Jan

  • 10

    Jan

  • 26

    Feb

  • 29

    May

AGL

AGL Resources

$0.00

(0.00%)

, ARCT

Arcturus Therapeutics

$9.47

-0.0099 (-0.10%)

08:18
01/08/18
01/08
08:18
01/08/18
08:18
Conference/Events
LifeSci Advisors to hold a conference »

LifeSci Advisors…

AGL

AGL Resources

$0.00

(0.00%)

ARCT

Arcturus Therapeutics

$9.47

-0.0099 (-0.10%)

CRMD

CorMedix

$0.55

-0.0163 (-2.87%)

GLMD

Galmed

$10.70

0.92 (9.41%)

COOL

Ticker changed to PTE

$24.06

0.6 (2.56%)

ICAD

iCAD

$3.88

-0.12 (-3.00%)

CYAD

Celyad

$46.50

1 (2.20%)

HTGM

HTG Molecular

$3.47

-0.56 (-13.90%)

NERV

Minerva

$6.00

-0.05 (-0.83%)

NTEC

Intec Pharma

$7.05

0.2 (2.92%)

CTSO

CytoSorbents

$7.05

0.2 (2.92%)

RXDX

Ignyta

$27.00

(0.00%)

TXMD

TherapeuticsMD

$6.42

-0.01 (-0.16%)

VBIV

VBI Vaccines

$4.44

0.01 (0.23%)

VRML

Vermillion

$1.85

0.041 (2.27%)

MRTX

Mirati Therapeutics

$18.70

-0.4 (-2.09%)

FBIO

Fortress Biotech

$4.20

0.01 (0.24%)

FOMX

Foamix

$6.28

-0.36 (-5.42%)

BDSI

BioDelivery Sciences

$3.00

0.1 (3.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

  • 08

    Jan

  • 08

    Jan

  • 10

    Jan

  • 26

    Feb

  • 29

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.